Compare Neurocrine Biosciences Inc (NBIX) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Tractor Supply Co — how do they compare? Neurocrine Biosciences Inc trades at $141.09 (market cap $14.36B), while Tractor Supply Co trades at $33.5 (market cap $17.44B). The key difference: Tractor Supply Co is the larger of the two by market cap, and Tractor Supply Co pays a 2.87% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Neurocrine Biosciences Inc for 23 Days and Tractor Supply Co for 88 Days on average.
| NBIX | TSCO | |
|---|---|---|
Market Cap | $14.36B | $17.44B |
Volume | 1,237,180 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $185.50 | $56.37 |
52-Week Low | $123.10 | $29.14 |
Typical Hold Time | 23 Days | 88 Days |
Enterprise Value | $14.37B | $23.76B |
Dividend Yield | — | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $143.47, down 1.4% on the day, amid a bearish technical signal. The stock shows strong fundamentals with a 20.91% net income margin and consistent earnings beats, including a Q2 2026 EPS of $2.85 versus $1.85 expected. Recent news highlights pipeline advancements in Prader-Willi syndrome and active participation in investor conferences. Key support is at $142, with resistance at $145.
The outlook is positive, driven by robust product growth, particularly from Ingrezza and Crenessity, and a deep pipeline. Risks include pricing pressures on Ingrezza by 2029 and execution challenges in portfolio expansion. Analyst consensus is strongly bullish with a $204.18 price target, suggesting significant upside from current levels.
Tractor Supply (TSCO) trades at $32.52, up 0.71% today, with a bullish technical signal from moving averages. The company reported revenue growth to $15.52B in 2025, but net income margin has declined to 6.42%, and it missed earnings estimates for three consecutive quarters. Recent news highlights community initiatives and a new distribution center opening, while some institutional investors reduced positions.
Outlook is mixed: analyst consensus is a Buy with a $36.76 price target, but earnings misses and margin pressure pose risks. The dividend streak remains a positive, yet competitive and cyclical headwinds require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
